|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
-
Evaluation of The Clinical Potential in Prostate Cancer Using Maintrac® Exploring the use of circulating epithelial tumour cell tracking (CETCs) to inform personalised and integrative approaches in cancer support *** DESCRIPTION Prostate cancer remains the most common cancer among men, with risk increasing significantly with age. Many cases involve slow-growing, less aggressive tumours that can develop slowly over a period
Free
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
DISCLAIMER: THIS SITE DOES NOT PROVIDE MEDICAL ADVICE
The information on these webpages and AONM webinars is intended for educational and informative purposes only and is not intended as a substitute for medical or professional advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health care provider with regards to any questions you may have regarding a medical condition or treatment before undertaking a health care regimen. Never disregard or delay seeking professional medical advice because of information you have read or seen on this website. AONM may assist and guide patients and practitioners with regards to which tests are appropriate to take, but any tests taken through AONM do not constitute a medical diagnosis on the part of AONM. AONM makes no claims whatsoever to be able to diagnose medical conditions but to provide tests which can help to form the basis of a diagnosis on the part of qualified practitioners.